share_log

Teachers Retirement System of The State of Kentucky Sells 22,248 Shares of Cardiovascular Systems, Inc. (NASDAQ:CSII)

Teachers Retirement System of The State of Kentucky Sells 22,248 Shares of Cardiovascular Systems, Inc. (NASDAQ:CSII)

肯塔基州教师退休系统出售22,248股心血管系统公司(纳斯达克代码:CSII)
Defense World ·  2022/09/28 04:31

Teachers Retirement System of The State of Kentucky lessened its holdings in shares of Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating) by 68.8% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,100 shares of the medical device company's stock after selling 22,248 shares during the period. Teachers Retirement System of The State of Kentucky's holdings in Cardiovascular Systems were worth $228,000 as of its most recent filing with the SEC.

肯塔基州教师退休系统公司在提交给美国证券交易委员会的最新Form 13F文件中称,该公司第一季度减持了68.8%的心血管系统公司股票。该公司在此期间出售了22,248股票后,拥有这家医疗器械公司的10,100股票。肯塔基州教师退休制度截至最近提交给美国证券交易委员会的文件,肯塔基州持有的心血管系统公司价值228,000美元。

Several other institutional investors also recently modified their holdings of CSII. Cubist Systematic Strategies LLC grew its stake in shares of Cardiovascular Systems by 1,124.7% in the fourth quarter. Cubist Systematic Strategies LLC now owns 176,858 shares of the medical device company's stock worth $3,321,000 after purchasing an additional 162,417 shares during the last quarter. Grandeur Peak Global Advisors LLC grew its stake in shares of Cardiovascular Systems by 36.2% in the fourth quarter. Grandeur Peak Global Advisors LLC now owns 564,582 shares of the medical device company's stock worth $10,603,000 after purchasing an additional 150,103 shares during the last quarter. Federated Hermes Inc. bought a new stake in shares of Cardiovascular Systems in the first quarter worth $2,697,000. Royal Bank of Canada lifted its holdings in Cardiovascular Systems by 89.0% in the first quarter. Royal Bank of Canada now owns 187,700 shares of the medical device company's stock valued at $4,242,000 after buying an additional 88,376 shares during the period. Finally, BlackRock Inc. lifted its holdings in Cardiovascular Systems by 1.1% in the first quarter. BlackRock Inc. now owns 7,087,402 shares of the medical device company's stock valued at $160,176,000 after buying an additional 80,138 shares during the period. Institutional investors own 91.72% of the company's stock.

其他几家机构投资者最近也调整了对中证二号的持股。Cubist Systems Strategy LLC第四季度在心血管系统公司的股份增加了1124.7%。Cubist Systems Strategy LLC在上个季度额外购买了162,417股后,现在拥有176,858股这家医疗设备公司的股票,价值3,321,000美元。宏伟高峰全球顾问有限责任公司第四季度在心血管系统公司的持股增加了36.2%。宏伟的Peak Global Advisors LLC现在拥有564,582股这家医疗设备公司的股票,价值10,603,000美元,在上个季度又购买了150,103股。今年第一季度,联合爱马仕公司购入了价值269.7万美元的心血管系统新股。加拿大皇家银行在第一季度增持心血管系统89.0%。加拿大皇家银行现在持有这家医疗器械公司187,700股股票,价值4,242,000美元,在此期间又购买了88,376股。最后,贝莱德股份有限公司在第一季度增持了心血管系统公司的股份1.1%。贝莱德股份有限公司目前持有这家医疗器械公司7,087,402股股票,价值160,176,000美元,在此期间又购买了80,138股。机构投资者持有该公司91.72%的股票。

Get
到达
Cardiovascular Systems
心血管系统
alerts:
警报:

Cardiovascular Systems Price Performance

心血管系统性价比

CSII stock opened at $13.30 on Wednesday. The firm has a market cap of $544.83 million, a price-to-earnings ratio of -14.00 and a beta of 0.97. The company has a quick ratio of 5.19, a current ratio of 6.05 and a debt-to-equity ratio of 0.08. Cardiovascular Systems, Inc. has a 12-month low of $12.51 and a 12-month high of $36.97. The company's fifty day simple moving average is $14.86 and its 200 day simple moving average is $16.62.

CSII股票周三开盘报13.30美元。该公司市值为5.4483亿美元,市盈率为-14.00倍,贝塔系数为0.97。该公司的速动比率为5.19,流动比率为6.05,债务权益比率为0.08。心血管系统公司的股价为12.51美元的12个月低点和36.97美元的12个月高位。该公司的50日简单移动均线切入位为14.86美元,200日简单移动均线切入位为16.62美元。

Cardiovascular Systems Profile

心血管系统概况

(Get Rating)
(获取评级)

Cardiovascular Systems, Inc, a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.

心血管系统公司是一家医疗技术公司,在美国和国际上开发和销售治疗外周和冠状动脉疾病的解决方案。该公司提供外周动脉疾病产品,包括基于导管的平台,用于治疗膝盖以上和膝盖以下的各种斑块类型,包括钙化斑块,以及解决与手术、导管和药物治疗替代方案相关的各种限制;以及外周支持产品。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on Cardiovascular Systems (CSII)
  • Defensive Stocks For A Volatile Market
  • Will UPS Be Next to Deliver a Warning?
  • SunPower Is Ready To Power Up Triple-Digit Earnings Gains
  • Is This the Darkest Before the Dawn for Gap Stock?
  • Build A Better Tech Portfolio With Jabil Inc.
  • 免费获取StockNews.com心血管系统研究报告(CSII)
  • 防御性股票应对动荡的市场
  • UPS会成为下一个发出警告的公司吗?
  • SunPower准备推动三位数的收益增长
  • 这是Gap Stock黎明前最黑暗的一次吗?
  • 与捷普公司一起打造更好的技术产品组合。

Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating).

想看看其他对冲基金持有哪些中证指数吗?访问HoldingsChannel.com获取心血管系统公司(纳斯达克代码:CSII-GET评级)的最新13F申报文件和内幕交易信息。

Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.

接受《每日心血管系统》新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对心血管系统和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发